Erlotinib hydrochloride For Treat Non-small Cell Lung Cancer 183319-69-9 

Product Description
99% Erlotinib Hydrochloride Antitumor Drugs Factory Sypplying 183319-69-9

Product Description
Erlotinib hydrochloride For Treat Non-small Cell Lung Cancer 183319-69-9

Erlotinib hydrochloride———Basic info

Product Name Erlotinib hydrochloride
CAS 183319-69-9
MF C22H24ClN3O4
MW 429.9
Chemical Properties Off-White Solid
Usage Selective epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor. Antineoplastic
Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM.
Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3.

Erlotinib hydrochloride———Description

Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR).

Author: chemicals

Here is chemical sourse

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s